We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Help improve GOV.UK Sign up to take part in user research (opens in a new tab)
Legal requirements referred to in Schedule 1 of the Veterinary Medicines Regulations, as amended.
Advisory note from the UK Chief Veterinary Officer for veterinarians prescribing BTV-3 vaccines.
How to submit an application, data package and responses for proposed or existing marketing authorisations.
Urgent and clinically significant safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.
How a marketing authorisation holder should report a defect with a veterinary medicine.
Placing a veterinary medicine on the market, including non-medicinal products, how to obtain advice and report non-compliance.
Guidance for the pharmaceutical industry on how to apply for an authorisation to place a veterinary medicine on the UK market or part of, or to expire one.
Legal requirements for the sale of veterinary medicines on the internet.
Guidance for the veterinary pharmaceutical industry on applying for maximum residue limits (MRLs) in the UK.
Clarification for the interpretation of the new elements within the Veterinary Medicines Regulations (VMRs), as amended, relating to combating antimicrobial resistance (AMR).
How to apply for an authorisation to manufacture authorised veterinary medicines or medicines marketed under the Exemptions for small pet animals.
Guidance for the veterinary pharmaceutical industry on how to apply for and maintain a shared-label for use on veterinary medicines placed on the market in the UK and Ireland.
Requirement to analyse samples from food producing animals for residues of veterinary medicines and prohibited substances.
The following requirements shall apply to immunological veterinary medicinal products, except where otherwise set out in Section IV.
Requirements for suitable and adequate premises and equipment to ensure proper storage and distribution of veterinary medicinal products.
All national applications will be processed on one of six timetables that vary in length depending on the complexity and nature of the application under assessment.
Guidance for the veterinary pharmaceutical industry on the production and submission of the Summary of Product Characteristics (SPCs) and product literature mock-ups.
How to report an adverse event to animal medicine using the VMD's online reporting service.
This enforcement policy sets out the general principles and approach taken by the VMD.
A quality system is required to ensure that the objectives of good distribution practice are realised and should clearly set out responsibilities, processes and risk management principles in relation to the wholesale dealers…
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).